Letter to Editor

Comment on: Pan-immune-inflammation value and platelet indices as mortality markers in intensive care patients with sepsis

Volume: 7 Number: 2 May 31, 2026
EN TR

Comment on: Pan-immune-inflammation value and platelet indices as mortality markers in intensive care patients with sepsis

Abstract

Sepsis remains a leading cause of morbidity and mortality worldwide and represents a major diagnostic and prognostic challenge in the emergency department, where early risk stratification is essential for timely clinical decision-making. In this letter, we comment on the recently published study by Çetin et al., which evaluated the prognostic value of the Pan-Immune Inflammation Value (PIIV) and platelet indices, particularly mean platelet volume (MPV), in intensive care unit patients with sepsis. The authors demonstrated that both PIIV and MPV were independently associated with 30-day mortality, highlighting the potential clinical utility of composite inflammatory indices derived from routine complete blood count parameters. From an emergency medicine perspective, biomarkers that are rapidly available, low-cost, and easily calculated may contribute significantly to early assessment and disposition decisions, including intensive care unit admission. While the reported discriminative performance of PIIV and MPV was moderate, these findings provide a valuable foundation for further investigation. Prospective studies including patients at the time of emergency department presentation, as well as analyses of dynamic changes in these indices, may help clarify their role in early sepsis management. Overall, this study adds to the growing evidence supporting the use of composite inflammatory markers across the continuum of sepsis care.

Keywords

References

  1. 1. Çetin AU, Ünal Çetin E, Kurtkulağı Ö, vd. Pan-immune-inflammation value and platelet indices as mortality markers in intensive care patients with sepsis. Troia Med J. 2026;7(1):10-18.
  2. 2. Long B, Gottlieb M. Emergency medicine upda-tes: Evaluation and diagnosis of sepsis and sep-tic shock. Am J Emerg Med 2025;90:169-78.
  3. 3. Gyawali B, Ramakrishna K, Dhamoon AS. Sep-sis: the evolution in definition, pathophysio-logy, and management. SAGE Open Med 2019;7:2050312119835043.
  4. 4. Fucà G, Guarini V, Antoniotti C, et al. The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer. Br J Cancer 2020;123(3):403-9.
  5. 5. Korniluk A, Koper-Lenkiewicz OM, Kamińska J, et al. Mean platelet volume (MPV): new pers-pectives for an old marker. Mediators Inflamm 2019;2019:9213074.
  6. 6. Xu HB, Xu YH, He Y, et al. Association between admission pan-immune inflammation value and short-term mortality in septic patients. Sci Rep 2024;14(1):15205.
  7. 7. Djordjevic D, Rondovic G, Surbatovic M, et al. Mean platelet volume as a predictor of outcome in sepsis. Mediators Inflamm 2018;2018:3758068.

Details

Primary Language

English

Subjects

Emergency Medicine

Journal Section

Letter to Editor

Publication Date

May 31, 2026

Submission Date

January 27, 2026

Acceptance Date

April 26, 2026

Published in Issue

Year 2026 Volume: 7 Number: 2

APA
Ayyıldız, F. A. (2026). Comment on: Pan-immune-inflammation value and platelet indices as mortality markers in intensive care patients with sepsis. Troia Medical Journal, 7(2), 130-131. https://doi.org/10.55665/troiamedj.1873294
AMA
1.Ayyıldız FA. Comment on: Pan-immune-inflammation value and platelet indices as mortality markers in intensive care patients with sepsis. Troia Med J. 2026;7(2):130-131. doi:10.55665/troiamedj.1873294
Chicago
Ayyıldız, Fatih Alper. 2026. “Comment On: Pan-Immune-Inflammation Value and Platelet Indices As Mortality Markers in Intensive Care Patients With Sepsis”. Troia Medical Journal 7 (2): 130-31. https://doi.org/10.55665/troiamedj.1873294.
EndNote
Ayyıldız FA (May 1, 2026) Comment on: Pan-immune-inflammation value and platelet indices as mortality markers in intensive care patients with sepsis. Troia Medical Journal 7 2 130–131.
IEEE
[1]F. A. Ayyıldız, “Comment on: Pan-immune-inflammation value and platelet indices as mortality markers in intensive care patients with sepsis”, Troia Med J, vol. 7, no. 2, pp. 130–131, May 2026, doi: 10.55665/troiamedj.1873294.
ISNAD
Ayyıldız, Fatih Alper. “Comment On: Pan-Immune-Inflammation Value and Platelet Indices As Mortality Markers in Intensive Care Patients With Sepsis”. Troia Medical Journal 7/2 (May 1, 2026): 130-131. https://doi.org/10.55665/troiamedj.1873294.
JAMA
1.Ayyıldız FA. Comment on: Pan-immune-inflammation value and platelet indices as mortality markers in intensive care patients with sepsis. Troia Med J. 2026;7:130–131.
MLA
Ayyıldız, Fatih Alper. “Comment On: Pan-Immune-Inflammation Value and Platelet Indices As Mortality Markers in Intensive Care Patients With Sepsis”. Troia Medical Journal, vol. 7, no. 2, May 2026, pp. 130-1, doi:10.55665/troiamedj.1873294.
Vancouver
1.Fatih Alper Ayyıldız. Comment on: Pan-immune-inflammation value and platelet indices as mortality markers in intensive care patients with sepsis. Troia Med J. 2026 May 1;7(2):130-1. doi:10.55665/troiamedj.1873294